GR1003868B - Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους - Google Patents

Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους

Info

Publication number
GR1003868B
GR1003868B GR20010100053A GR2001100053A GR1003868B GR 1003868 B GR1003868 B GR 1003868B GR 20010100053 A GR20010100053 A GR 20010100053A GR 2001100053 A GR2001100053 A GR 2001100053A GR 1003868 B GR1003868 B GR 1003868B
Authority
GR
Greece
Prior art keywords
antioxidant
wound healing
mastic
evaluation
pharmaceutical
Prior art date
Application number
GR20010100053A
Other languages
English (en)
Inventor
Προκοπιος Μαγιατης
Σοφια Μητακου
Αλεξιος-Λεανδρος Σκαλτσουνης
Σπυριδων Φωτεινος
Original Assignee
Lavipharm S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lavipharm S.A. filed Critical Lavipharm S.A.
Priority to GR20010100053A priority Critical patent/GR1003868B/el
Publication of GR1003868B publication Critical patent/GR1003868B/el

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

παρούσα εφεύρεση αναφέρεται στην χρήση προιόντος που προέρχεται απο το φυτό Pistacia lentiscus var. chia της οικογενείας Anacardiaceae σαν αντιοξειδωτικό, επουλωτικό και κυτταροστατικό. Η εφεύρεση επίσης ανφέρεται και στην χρησιμοποίηση του προιόντος για την παρασκευή φαρμακευτικού σκευάσματος. Το φαρμακευτικό σκεύασμα μπορεί να επιλεγεί απο την ομάδα που περιλαμβάνει εκτός των άλλων δισκία, κρέμες, αλοιφές, διαλύματα, εναιωρήματα, γέλες (υδογέλες), shampoo, επιδερμικά και διαδερμικά επιθέματα (patches), συστήματα για την χορήγηση μέσω βλεννογόνων και συστήματα για την χορήγηση μέσω του βλεννογόνου της στοματικής κοιλότητας. ΰ
GR20010100053A 2001-02-06 2001-02-06 Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους GR1003868B (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20010100053A GR1003868B (el) 2001-02-06 2001-02-06 Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20010100053A GR1003868B (el) 2001-02-06 2001-02-06 Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους

Publications (1)

Publication Number Publication Date
GR1003868B true GR1003868B (el) 2002-04-19

Family

ID=10944633

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010100053A GR1003868B (el) 2001-02-06 2001-02-06 Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους

Country Status (1)

Country Link
GR (1) GR1003868B (el)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092712A1 (en) * 2002-05-01 2003-11-13 Lavipharm S.A. Use of mastic and its components for the control of microbial infections
EP1520585A1 (en) * 2003-10-02 2005-04-06 Data Medica Padova S.p.A. Cancer treatment using natural plant products or essential oils or components from some pistacia species
WO2010100650A2 (en) 2009-03-04 2010-09-10 Regenera Pharma Ltd. Therapeutic uses of mastic gum fractions
WO2012032523A2 (en) 2010-09-07 2012-03-15 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
US8722105B2 (en) 2009-03-04 2014-05-13 Zadik Hazan Compositions of polymeric myrcene
EP3363448A1 (en) 2017-02-15 2018-08-22 Phytoitalia SRL Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
WO2019170239A1 (en) 2018-03-08 2019-09-12 Phytoitalia Srl Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563109A1 (fr) * 1984-04-18 1985-10-25 Truc Daniel Composition de phytotherapie composee de vegetaux a essences, de vegetaux a sels mineraux, de vegetaux a cires, oxydases et sels mineraux, qui traite les maladies des voies respiratoires et son procede de preparation
CN1154852A (zh) * 1996-05-05 1997-07-23 于庆林 一种多用途外伤膏
US5725859A (en) * 1994-05-03 1998-03-10 Omer; Osama L.M. Plant-based therapeutic agent with virustatic and antiviral effect
WO2001021212A1 (en) * 1999-09-22 2001-03-29 Vassilios Papageorgiou A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563109A1 (fr) * 1984-04-18 1985-10-25 Truc Daniel Composition de phytotherapie composee de vegetaux a essences, de vegetaux a sels mineraux, de vegetaux a cires, oxydases et sels mineraux, qui traite les maladies des voies respiratoires et son procede de preparation
US5725859A (en) * 1994-05-03 1998-03-10 Omer; Osama L.M. Plant-based therapeutic agent with virustatic and antiviral effect
CN1154852A (zh) * 1996-05-05 1997-07-23 于庆林 一种多用途外伤膏
WO2001021212A1 (en) * 1999-09-22 2001-03-29 Vassilios Papageorgiou A stable product of isohexylnaphthazarins with penta- and tetra-cyclic triterpenes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A.-H. Y. ABDEL-RAHMAN ET AL.: "MASTICH AS AN ANTIOXIDANT", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY., vol. 52, no. 10, 1975, AMERICAN OIL CHEMISTS' SOCIETY. CHAMPAIGN., US, pages 423, XP001024781, ISSN: 0003-021X *
C.B. LESESNE: "THE POSTOPERATIVE USE OF WOUND ADHESIVES", JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, vol. 18, no. 11, November 1992 (1992-11-01), pages 990, XP001030919 *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092712A1 (en) * 2002-05-01 2003-11-13 Lavipharm S.A. Use of mastic and its components for the control of microbial infections
EP1520585A1 (en) * 2003-10-02 2005-04-06 Data Medica Padova S.p.A. Cancer treatment using natural plant products or essential oils or components from some pistacia species
US9655938B2 (en) 2009-03-04 2017-05-23 Regenera Pharma Ltd. Compositions of polymeric myrcene
CN106619700A (zh) * 2009-03-04 2017-05-10 瑞吉纳拉制药公司 乳香部分的治疗应用
US8722105B2 (en) 2009-03-04 2014-05-13 Zadik Hazan Compositions of polymeric myrcene
AU2010220057B2 (en) * 2009-03-04 2015-04-02 Regenera Pharma Ltd. Compositions of polymeric myrcene
AU2010220057C1 (en) * 2009-03-04 2015-10-29 Regenera Pharma Ltd. Compositions of polymeric myrcene
EP3578191A1 (en) 2009-03-04 2019-12-11 Regenera Pharma Ltd. Compositions of polymeric myrcene
US9364509B2 (en) 2009-03-04 2016-06-14 Regenera Pharma Ltd. Therapeutic uses of mastic gum fractions
US10806763B2 (en) 2009-03-04 2020-10-20 Regenera Pharma Ltd. Compositions of polymeric myrcene
WO2010100650A2 (en) 2009-03-04 2010-09-10 Regenera Pharma Ltd. Therapeutic uses of mastic gum fractions
US10307449B2 (en) 2009-03-04 2019-06-04 Regenera Pharma Ltd. Compositions of polymeric myrcene
US10251923B2 (en) 2009-03-04 2019-04-09 Regenera Pharma Ltd. Therapeutic uses of mastic gum fractions
US10159680B2 (en) 2010-09-07 2018-12-25 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
WO2012032523A2 (en) 2010-09-07 2012-03-15 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
US10561670B2 (en) 2010-09-07 2020-02-18 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
US9271949B2 (en) 2010-09-07 2016-03-01 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
EP3581177A2 (en) 2010-09-07 2019-12-18 Regenera Pharma Ltd. Compositions comprising acidic extracts of mastic gum
EP3363448A1 (en) 2017-02-15 2018-08-22 Phytoitalia SRL Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
WO2019170239A1 (en) 2018-03-08 2019-09-12 Phytoitalia Srl Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them

Similar Documents

Publication Publication Date Title
EP4442241A3 (en) Retinol replacement in skin treatment
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
MXPA03001855A (es) Composiciones peliculares de pectina.
AU2002235930A1 (en) A process for the manufacture of a herbal composition comprising a matrine
BG108516A (en) Pharmaceutical formulation
BR0312728A (pt) Formulação em tablete dispersìvel e processo para sua preparação
GR1003868B (el) Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
EP4400098A3 (en) Co-amorphous forms of beta-lactoglobulin and a drug substance
WO2005065639A3 (en) Novel pharmaceutical compositions
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
MXPA05008843A (es) Sistema terapeutico que comprende amoxicilina y acido clavulanico.
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
MX2021014830A (es) Conjugados de compuestos que comprenden nitrogeno heteroaromatico donador de pares de electrones pi.
TW200612903A (en) Use of trisubstituted benzopyranones
WO2005076761A3 (en) Composition for preenting a cold
WO2023150579A3 (en) Pharmaceutical formulations containing nalbuphine
WO2012010938A3 (en) Pharmaceutical composition of cefditoren pivoxil
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
WO2005020968A3 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
NO20005341D0 (no) Behandling av depresjon og farmasøytiske sammensetninger til dette
GR20020100071A (el) Αξιολογηση της αντιοξειδωτικης και κυτταροπροστατευτικης ικανοτητας του 5-(αιθυλιδενο-2-οξο-τετραυδρο-πυρανυλ-4) οξικου οξεως και εκχυλισματων απο ελιες, ελαιολαδο, αποβλητα ελαιοτριβειων και φυλλα ελαιοδενδρων, και οι εφαρμογες τους
HU0200980D0 (el)
MX2024012473A (es) Formulaciones farmaceuticas de liberacion modificada que comprenden deferiprona
WO2003006668A3 (en) Haptoglobin Derived Antioxidants